We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
976
DELISTED
Sage Therapeutics
SAGE
| $420K | ﹤0.01% |
10,742
+292
| +3% | +$11.3K |
|
977
Fate Therapeutics
FATE
$281M
| $418K | ﹤0.01% |
18,636
+427
| +2% | +$12.3K |
|
978
Rithm Capital
RITM
$5.09B
| $414K | ﹤0.01% |
56,690
-3,110
| -5% | -$29.6K |
|
|
NUVA
979
DELISTED
NuVasive, Inc.
NUVA
| $414K | ﹤0.01% |
9,446
-149
| -2% | -$7.22K |
|
980
Cognex
CGNX
$10.3B
| $413K | ﹤0.01% |
9,954
-118
| -1% | -$5.34K |
|
981
Lennox International
LII
$18.8B
| $413K | ﹤0.01% |
1,853
-63
| -3% | -$15K |
|
982
iRhythm Holdings
IRTC
$3.59B
| $412K | ﹤0.01% |
3,290
-64
| -2% | -$9.24K |
|
|
ISEE
983
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $412K | ﹤0.01% |
22,998
+806
| +4% | +$10.6K |
|
984
Varonis Systems
VRNS
$5.25B
| $409K | ﹤0.01% |
15,457
-882
| -5% | -$25.2K |
|
985
Tradeweb Markets
TW
$21.3B
| $407K | ﹤0.01% |
7,218
-400
| -5% | -$27.2K |
|
986
Ameris Bancorp
ABCB
$5.89B
| $405K | ﹤0.01% |
9,073
-254
| -3% | -$11.6K |
|
987
WSFS Financial
WSFS
$4.1B
| $404K | ﹤0.01% |
8,698
-397
| -4% | -$18.6K |
|
988
Blackbaud
BLKB
$1.5B
| $403K | ﹤0.01% |
9,121
-434
| -5% | -$23.4K |
|
989
Twilio
TWLO
$29.1B
| $403K | ﹤0.01% |
5,821
-840
| -13% | -$67.1K |
|
|
ENV
990
DELISTED
ENVESTNET, INC.
ENV
| $403K | ﹤0.01% |
9,077
-132
| -1% | -$7.04K |
|
|
RXDX
991
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $402K | ﹤0.01% |
+6,814
| New | +$312K |
|
992
Lear
LEA
$7.19B
| $400K | ﹤0.01% |
3,343
-59
| -2% | -$8.15K |
|
|
PPBI
993
DELISTED
Pacific Premier Bancorp
PPBI
| $400K | ﹤0.01% |
12,924
-333
| -3% | -$10.8K |
|
994
Advanced Energy
AEIS
$12.2B
| $399K | ﹤0.01% |
5,158
-141
| -3% | -$12.1K |
|
995
Diodes
DIOD
$4B
| $398K | ﹤0.01% |
6,146
-154
| -2% | -$11.1K |
|
996
EnerSys
ENS
$6.95B
| $397K | ﹤0.01% |
6,829
-212
| -3% | -$13.5K |
|
997
Middleby
MIDD
$6.05B
| $396K | ﹤0.01% |
3,091
-61
| -2% | -$8.56K |
|
998
Relay Therapeutics
RLAY
$4.02B
| $394K | ﹤0.01% |
17,595
+538
| +3% | +$11.8K |
|
|
COOP
999
DELISTED
Mr. Cooper
COOP
| $393K | ﹤0.01% |
9,709
-568
| -6% | -$24K |
|
1000
Tenet Healthcare
THC
$20.1B
| $393K | ﹤0.01% |
7,617
-67
| -0.9% | -$3.98K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.